Navigation Links
SeraCare Life Sciences Expands R&D Facilities
Date:9/20/2013

MILFORD, Mass., Sept. 20, 2013 /PRNewswire/ -- SeraCare Life Sciences, a manufacturer of life sciences tools, bulk plasma, and quality controls for diagnostic companies and clinical laboratories, announced an expansion of its research and manufacturing facilities at its Milford, Massachusetts headquarters. The addition of the state-of-the-art facility was driven by new companion diagnostic manufacturing opportunities with key diagnostic partners and enhances the company's ability to manufacture innovative molecular diagnostic kits and components used in in vitro diagnostics and companion diagnostics under stringent design control and quality systems.

"The expansion of our research and manufacturing capabilities is an important element in our overall growth strategy for SeraCare," said Charlie Mamrak, CEO of SeraCare. "Over the past year, we have made a number of significant investments including the recent acquisition of KPL, a leader in immunoassay reagents, and implementation of SAP enterprise resource planning software. These investments position SeraCare for continued growth in both our existing customer base as well as emerging markets such as molecular and companion diagnostics."

Under this initiative, SeraCare is adding five thousand square feet of space to its Milford research and manufacturing building. This state-of-the-art facility will include an ISO 8 classified clean room, four advanced molecular laboratories and a sophisticated air handling and purifying system. The new laboratories will also feature polymerase chain reaction (PCR) capabilities, amplicon segregation process design and sequencing instrumentation to aid in the development of molecular diagnostic kits and components.

About SeraCare Life Sciences
SeraCare, a portfolio company of Linden Capital Partners, works with diagnostics researchers, IVD manufacturers, and clinical laboratories to shape the future of medical diagnostics. Our innovative portfolio includes ACCURUN® quality controls, AccuTrak, AccuSpan, AccuSet and AccuVert panels, KPL antibodies and immunoassay reagents, SeraCon processed plasma, specialty human blood products, and Complete BioCollections materials. SeraCare helps bridge the gap between today's diagnostic solutions and tomorrow's emerging technologies.

About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life science industries. Linden's strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, and services segments of healthcare.

Marsha Ann Marsh
SeraCare Life Sciences
+1 508.244.6400 ext. 6106
mmarsh@seracare.com


'/>"/>
SOURCE SeraCare Life Sciences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Edison initiates coverage of Derma Sciences
2. Updated: Harwood Feffer LLP Announces Investigation of Edwards Lifesciences Corporation
3. Sangamo BioSciences Announces Pricing Of Public Offering Of Common Stock
4. Frost & Sullivan Lauds LI-COR Biosciences for Developing NIR Fluorescence, One of the Most Remarkable Advancements in the Biomedical Industry
5. Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
6. Sangamo BioSciences Announces Presentation of Clinical Data Demonstrating Functional Control of Viremia in HIV-Infected Subjects Treated with SB-728-T
7. Aethlon Medical Announces Launch of Exosome Sciences Subsidiary
8. Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, Poland
9. Debiopharm Group and TCG Lifesciences Ltd. Enter into an Exclusive Research Agreement to Develop a Novel Class of Antibiotics, a New Strategic Therapeutic Area for Debiopharm
10. BioDelivery Sciences to Present at the Stifel Nicolaus 2013 Healthcare Conference
11. Endo and BioDelivery Sciences Provide Update on BEMA Buprenorphine Phase III Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 According to a new ... Pen Needles, Safety Pen Needles), Needle Length (4mm, 5mm, ... Mode of Purchase (Retail, Non-Retail) - Trends & Global ... the market for the forecast period of 2016 to ... Billion by 2021 from USD 1.65 Billion in 2016, ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):